1. Home
  2. EFSI vs VYGR Comparison

EFSI vs VYGR Comparison

Compare EFSI & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Financial Services Inc

EFSI

Eagle Financial Services Inc

HOLD

Current Price

$35.00

Market Cap

205.4M

Sector

Finance

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$4.15

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFSI
VYGR
Founded
1881
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.4M
194.0M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
EFSI
VYGR
Price
$35.00
$4.15
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$42.00
$17.00
AVG Volume (30 Days)
10.4K
497.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.59%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,135,000.00
Revenue This Year
$30.82
N/A
Revenue Next Year
$5.36
$71.77
P/E Ratio
$24.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.70
$2.65
52 Week High
$41.12
$5.55

Technical Indicators

Market Signals
Indicator
EFSI
VYGR
Relative Strength Index (RSI) 25.94 60.10
Support Level $34.96 $3.73
Resistance Level $36.96 $4.44
Average True Range (ATR) 0.98 0.24
MACD -0.39 0.08
Stochastic Oscillator 22.49 81.19

Price Performance

Historical Comparison
EFSI
VYGR

About EFSI Eagle Financial Services Inc

Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: